Twice‐weekly induction with ixazomib–lenalidomide–dexamethasone (IRd) combination followed by extended IRd consolidation and lenalidomide maintenance in transplant‐eligible patients with newly diagnosed multiple myeloma: Results of the phase 2 study IFM2014‐03

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Aurore Perrot, Murielle Roussel, Valerie Lauwers‐Cances, Cyrille Hulin, Xavier Leleu, Cyrille Touzeau, Thierry Facon, Clara Mariette, Jean‐Marc Schiano, Julie Gay, Lydia Montes, Dana Ranta, Amandine Huguet, Soraya Wuillème, Thomas Dejoie, Laure Devlamynck, Jill Corre, Hervé Avet‐Loiseau, Philippe Moreau, Michel Attal
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Similar Items